Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 7/20 | 1.00 |
| ▸ | FAAH | O00519 | 3/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.56 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.56 |
| ▸ | CPA1 | P15085 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
| ▸ | PAM | P19021 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | FNTA | P49354 | 1/20 | 0.47 |
| ▸ | FNTB | P49356 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1042453 | 1.00 | CES1 (1.00) | CES1FAAHCES2AKR1B1CPA1 | |
| SCHEMBL583920 | 0.88 | CES1 (0.78) | CES1FAAHMEN1KMT2AHDAC8 | |
| SCHEMBL4753311 | 0.84 | CES1 (0.71) | CES1FAAHCES2AKR1B1CPA1 | |
| SCHEMBL2381708 | 0.83 | CES1 (0.69) | CES1HDAC6 | |
| SCHEMBL16405134 | 0.83 | CES1 (0.70) | CES1FAAHCES2AKR1B1CPA1 | |
| SCHEMBL13498524 | 0.83 | CES1 (0.70) | CES1FAAHCES2AKR1B1CPA1 | |
| SCHEMBL9314779 | 0.83 | CES1 (0.70) | CES1FAAHCES2AKR1B1CPA1 | |
| SCHEMBL10433444 | 0.83 | CES1 (0.70) | CES1FAAHCES2AKR1B1CPA1 | |
| Phenylacetic Acid SCHEMBL27489228 | 0.80 | AKR1B1 (0.74) | CES1CES2AKR1B1CPA1PAM | |
| SCHEMBL10431529 | 0.80 | CES1 (0.67) | CES1FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1732531-A2 | AMINES AND AMIDES FOR THE TREATMENT OF DISEASES | LA JOLLA PHARMACEUTICAL COMPANY (US) | 2006-12-20 | — | — | EP | disclosed |
| WO-2005082343-A2 | AMINES AND AMIDES FOR THE TREATMENT OF DISEASES | LA JOLLA PHARMACEUTICAL COMPANY (US) | 2005-09-09 | — | — | WO | disclosed |